Researchers hope the database, named ImmuneCODE, will help the medical community better understand how T-cells respond to SARS-CoV-2, the virus that causes COVID-19. This availability of immunity data can lead scientists to find the most effective T-cell reaction and use the information to improve COVID-19 diagnostics and treatments.
The database consists of de-identified data from thousands of COVID-19 patients who are ethnically and geographically diverse.
More articles on data analytics:
HHS updates COVID-19 lab test data reporting requirements: 6 details
Apple updates sharing options on COVID-19 app
New York’s Mount Sinai gets Microsoft grant for COVID-19 data center: 4 details
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.